Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS · Delayed Price · Currency is USD
0.0971
-0.0006 (-0.59%)
At close: Nov 28, 2025
Oncotelic Therapeutics Market Cap
Oncotelic Therapeutics has a market cap or net worth of $42.81 million as of November 28, 2025. Its market cap has increased by 234.73% in one year.
Market Cap
42.81M
Enterprise Value
55.30M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.10
Market Cap Chart
Since April 23, 2019, Oncotelic Therapeutics's market cap has increased from 9.14M to 42.81M, an increase of 368.20%. That is a compound annual growth rate of 26.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 42.81M | 200.30% |
| Dec 31, 2024 | 14.26M | -6.64% |
| Dec 29, 2023 | 15.27M | -13.24% |
| Dec 30, 2022 | 17.60M | -71.94% |
| Dec 31, 2021 | 62.72M | 225.64% |
| Dec 31, 2020 | 19.26M | 34.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.79M |
| Elite Pharmaceuticals | 571.69M |
| Glass House Brands | 486.37M |
| American Oncology Network | 429.20M |
| CytoDyn | 414.34M |
| Northwest Biotherapeutics | 394.75M |
| Silence Therapeutics | 318.36M |
| Nika Pharmaceuticals | 259.96M |